AJP - Endo AJP: Advances in Physiology Education
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Endocrinol Metab 293: E1709-E1715, 2007. First published September 25, 2007; doi:10.1152/ajpendo.00444.2007
0193-1849/07 $8.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplemental Table
Right arrow All Versions of this Article:
293/6/E1709    most recent
00444.2007v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (3)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kotronen, A.
Right arrow Articles by Yki-Järvinen, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kotronen, A.
Right arrow Articles by Yki-Järvinen, H.

Effect of liver fat on insulin clearance

Anna Kotronen,1,2 Satu Vehkavaara,1 Anneli Seppälä-Lindroos,1 Robert Bergholm,1,2 and Hannele Yki-Järvinen1

1Department of Medicine, Division of Diabetes, University of Helsinki; and 2Minerva Medical Research Institute, Helsinki, Finland

Submitted 9 July 2007 ; accepted in final form 21 September 2007

A fatty liver is associated with fasting hyperinsulinemia, which could reflect either impaired insulin clearance or hepatic insulin action. We determined the effect of liver fat on insulin clearance and hepatic insulin sensitivity in 80 nondiabetic subjects [age 43 ± 1 yr, body mass index (BMI) 26.3 ± 0.5 kg/m2]. Insulin clearance and hepatic insulin resistance were measured by the euglycemic hyperinsulinemic (insulin infusion rate 0.3 mU·kg–1·min–1 for 240 min) clamp technique combined with the infusion of [3-3H]glucose and liver fat by proton magnetic resonance spectroscopy. During hyperinsulinemia, both serum insulin concentrations and increments above basal remained ~40% higher (P < 0.0001) in the high (15.0 ± 1.5%) compared with the low (1.8 ± 0.2%) liver fat group, independent of age, sex, and BMI. Insulin clearance (ml·kg fat free mass–1·min–1) was inversely related to liver fat content (r = –0.52, P < 0.0001), independent of age, sex, and BMI (r = –0.37, P = 0.001). The variation in insulin clearance due to that in liver fat (range 0–41%) explained on the average 27% of the variation in fasting serum (fS)-insulin concentrations. The contribution of impaired insulin clearance to fS-insulin concentrations increased as a function of liver fat. This implies that indirect indexes of insulin sensitivity, such as homeostatic model assessment, overestimate insulin resistance in subjects with high liver fat content. Liver fat content correlated significantly with fS-insulin concentrations adjusted for insulin clearance (r = 0.43, P < 0.0001) and with directly measured hepatic insulin sensitivity (r = –0.40, P = 0.0002). We conclude that increased liver fat is associated with both impaired insulin clearance and hepatic insulin resistance. Hepatic insulin sensitivity associates with liver fat content, independent of insulin clearance.

hepatic insulin resistance; homeostasis model assessment; fasting serum insulin



Address for reprint requests and other correspondence: A. Kotronen, Dept. of Medicine, Division of Diabetes, Univ. of Helsinki, P.O. Box 700, Rm. C418B, FIN-00029 HUCH, Helsinki, Finland (e-mail: anna.kotronen{at}helsinki.fi)




This article has been cited by other articles:


Home page
Diabetes CareHome page
G. Perseghin
Viewpoints on the Way to a Consensus Session: Where does insulin resistance start? The liver
Diabetes Care, November 1, 2009; 32(suppl_2): S164 - S167.
[Full Text] [PDF]


Home page
GutHome page
K Kantartzis, C Thamer, A Peter, J Machann, F Schick, C Schraml, A Konigsrainer, I Konigsrainer, S Krober, A Niess, et al.
High cardiorespiratory fitness is an independent predictor of the reduction in liver fat during a lifestyle intervention in non-alcoholic fatty liver disease
Gut, September 1, 2009; 58(9): 1281 - 1288.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
A. Kotronen, T. Seppanen-Laakso, J. Westerbacka, T. Kiviluoto, J. Arola, A.-L. Ruskeepaa, M. Oresic, and H. Yki-Jarvinen
Hepatic Stearoyl-CoA Desaturase (SCD)-1 Activity and Diacylglycerol but Not Ceramide Concentrations Are Increased in the Nonalcoholic Human Fatty Liver
Diabetes, January 1, 2009; 58(1): 203 - 208.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2007 by the American Physiological Society.